Germany’s Fresenius Medical Care has acquired the US-based company American Access Care Holdings (AAC) for $385 million. AAC operates 28 freestanding outpatients center that serve the vascular access needs of dialysis patients. The transaction is expected to add approximately $175 million to Fresenius’s annual revenue.
Fresenius said that acquiring AAC will enable it to achieve critical mass in its vascular access business, and that the deal has strategic importance because of the scale, resources and operational efficiency it brings to its vascular access operations. The company added that this is especially true given the US government’s proposal to include the type of access and the frequency of access-related infections within the quality outcome component of the dialysis bundled reimbursement system by 2014.
Headquartered in Bad Homburg, Germany, Fresenius is the world’s largest integrated provider of products and services for dialysis patients. Through its network of 2,838 dialysis clinics in North America, Europe, Latin America, the Asia-Pacific and Africa, the company provides dialysis treatment to 225,909 patients around the globe.
Fresenius is also the world’s leading provider of dialysis products including hemodialysis machines, dialysers and related disposable products.